Does Dr. SOLIMAR ACEVEDO SOTO have financial conflicts of interest?

Dr. SOLIMAR ACEVEDO SOTO (MD) has received a total of $280 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $280 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SOLIMAR ACEVEDO SOTO?

According to CMS Open Payments data, Dr. SOLIMAR ACEVEDO SOTO received funding from BOSTON SCIENTIFIC CORPORATION ($118), ASTRAZENECA PHARMACEUTICALS ($106), and JANSSEN PHARMACEUTICALS ($20).

Does Dr. SOLIMAR ACEVEDO SOTO receive research grants or speaking fees?

Dr. SOLIMAR ACEVEDO SOTO has received $280 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SOLIMAR ACEVEDO SOTO

MDReal-Time Hydrated

Specialty: Hospitalist

Practice Location: FORT MYERS, FL 33908

NPI Number: 1528676830

LIFETIME INDUSTRY VALUE

$280

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ACEVEDO SOTO is a verified Hospitalist practitioner based in FORT MYERS, FL.

Between 2021 and 2025, Dr. ACEVEDO SOTO had an overall industry promotional and research financial footprint of $280 as recorded in the federal CMS Open Payments database.

$280 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ACEVEDO SOTO's primary funding source is BOSTON SCIENTIFIC CORPORATION, which accounts for $118 (representing 42.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOSTON SCIENTIFIC CORPORATION

Rank 1

$118

42.1%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$106

37.8%

JANSSEN PHARMACEUTICALS

Rank 3

$20

7.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.